scispace - formally typeset
K

Kimberly A. McGuigan

Researcher at Pfizer

Publications -  46
Citations -  4964

Kimberly A. McGuigan is an academic researcher from Pfizer. The author has contributed to research in topics: Malpractice & Health care. The author has an hindex of 27, co-authored 46 publications receiving 4830 citations. Previous affiliations of Kimberly A. McGuigan include RAND Corporation & University of Kansas.

Papers
More filters
Journal ArticleDOI

Impact of medication adherence on hospitalization risk and healthcare cost.

TL;DR: For some chronic conditions, increased drug utilization can provide a net economic return when it is driven by improved adherence with guidelines-based therapy, producing a net reduction in overall healthcare costs.
Journal ArticleDOI

The Effect of Incentive-Based Formularies on Prescription-Drug Utilization and Spending

TL;DR: Different changes in formulary administration may have dramatically different effects on utilization and spending and may in some instances lead enrollees to discontinue therapy.
Journal ArticleDOI

Preventing adolescent drug use: long-term results of a junior high program.

TL;DR: It is unlikely that early prevention gains can be maintained without additional prevention efforts during high school, and future research is needed to develop and test such efforts.
Journal ArticleDOI

Early Predictors of Adolescent Violence

TL;DR: Deviant behavior in grade 7, poor grades, and weak bonds with middle school predicted violent behavior 5 years later, and girls with low self-esteem during early adolescence were more likely to hit others later on.
Journal ArticleDOI

A randomized clinical trial of outpatient comprehensive geriatric assessment coupled with an intervention to increase adherence to recommendations.

TL;DR: Comprehensive geriatric assessment has been demonstrated to confer health benefits in some settings, but its value in outpatient or office settings is uncertain.